Regular ArticleSelective Suppressions of Human CYP3A Forms CYP3A5 and CYP3A7 by Troglitazone in HepG2 Cells
References (21)
Human cytochromes P450: problems and prospects
Trends Pharmacol. Sci.
(1992)- et al.
Thiazolidinediones: an update
Lancet
(2000) - et al.
An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ)
J. Biol. Chem.
(1995) - et al.
Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcriptioncompetitive PCR
Biochem. Biophys. Res. Commun.
(2000) - et al.
Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction
Anal. Biochem.
(1987) - et al.
Structure and expression of the rat CYP3A1 gene: isolation of the gene (P450/6 βB) and characterization of the recombinant protein
Arch. Biochem. Biophys.
(1999) - et al.
Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene
Biochem. Biophys. Res. Commun.
(1999) - et al.
Cytochrome P450 regulation bv hepatocyte nuclear factor 4 In human hepatocyte: a study using adenovirus-mediated antisense targeting
Hepatology
(2001) - et al.
The organization, promoter analysis, and expression of the human PPARγ gene
J. Biol. Chem.
(1997) - et al.
Re-expression of C /EBPa induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells
FEBS Lett.
(1998)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2002 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.